Related Experiment Video
Updated: Jun 8, 2026
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Dendritic cells in cancer immunotherapy.
1Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. gerold.schuler@uk-erlangen.de
European Journal of Immunology
|September 21, 2010
Summary
Dendritic cells (DCs) are crucial for T-cell immunity and vaccine optimization. Exploring dendritic cell vaccination with mRNA-transfected DCs in clinical trials may enhance cancer vaccine efficacy.
Area of Science:
- Immunology
- Vaccinology
- Oncology
Background:
- Dendritic cells (DCs) play a pivotal role in initiating and regulating T-cell immunity.
- DCs are key targets for optimizing vaccine efficacy.
- Understanding DC biology presents opportunities to improve immunogenicity.
Purpose of the Study:
- To discuss recent developments in DC biology relevant to cancer vaccine clinical development.
- To emphasize the potential of adoptively transferred DCs (DC vaccination) for cancer vaccines.
- To propose specific strategies for advancing DC vaccination research.
Main Methods:
- Review of recent scientific literature and findings on DC biology.
- Discussion of insights relevant to clinical cancer vaccine development.
- Emphasis on a personal viewpoint regarding future research directions.
Main Results:
- Recent findings highlight opportunities to enhance vaccine immunogenicity through DC manipulation.
- Adoptively transferred DCs (DC vaccination) show promise as a cancer vaccine strategy.
- The need for well-designed clinical trials to address critical variables in DC vaccination is emphasized.
Conclusions:
- DC biology offers significant potential for improving cancer vaccines.
- Further research into DC vaccination, particularly using mRNA-transfected DCs, is warranted.
- Clinical trials are essential to validate and optimize DC-based cancer vaccine approaches.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:40Cell-mediated Immune Responses
Overview